Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25
United States Fiscal year ends December CIK 0001434316 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
44,444
$1.05
$46.67K
Cindy Tahl
6 May 2026
See Remarks
Exercised, kept
122,220
$1.32
$161.33K
William H Rastetter
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
Robert S Epstein
5 May 2026
Director
Exercised, kept
25,000
$1.69
$42.25K
John Mendlein
19 Jan 2023
Director
Exercised, kept
28,461
$1.37
$38.99K
Bahram Valamehr
12 Jan 2023
Chief R&D Officer
Exercised, kept
423
$1.37
$579.51
Showing 250 of 388 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 299
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 155
Sales at will 198
Transactions with no price 0
Shares from compensation/vesting 38,862,198
Sales filed before the plan box existed 178
History held since 7 Oct 2013